Alexandra (Ali) Urman

Alexandra (Ali) joined ARK as a Genomics analyst in February 2020. Her focus is on gene editing and novel immunotherapy technologies. Prior to ARK, Alexandra conducted clinical cancer research at Memorial Sloan Kettering Cancer Center and Montefiore Medical Center and was a Senior Research Program Manager at IBM Watson Health. She also created her on consulting firm in 2018. Alexandra has a Masters in Epidemiology and Community Health.